The Epithelial–Mesenchymal Transcription Factor SNAI1 Represses Transcription of the Tumor Suppressor miRNA let-7 in Cancer
Authors:
- Hanmin WangHWHanmin Wang
- Evgeny ChirshevECEvgeny Chirshev
- Nozomi HojoNHNozomi Hojo
- Tise SuzukiTSTise Suzuki
- Antonella BertucciABAntonella Bertucci
- Michael PierceMPMichael Pierce
- Christopher PerryCPChristopher Perry
- Ruining WangRWRuining Wang
- Jeffrey ZinkJZJeffrey Zink
- Carlotta A. GlackinCGCarlotta A. Glackin
- Yevgeniya J. IoffeYIYevgeniya J. Ioffe
- Juli J. UnternaehrerJUJuli J. Unternaehrer
Open Access
Abstract
We aimed to determine the mechanism of epithelial–mesenchymal transition (EMT)-induced stemness in cancer cells. Cancer relapse and metastasis are caused by rare stem-like cells within tumors. Studies of stem cell reprogramming have linked let-7 repression and acquisition of stemness with the EMT factor, SNAI1. The mechanisms for the loss of let-7 in cancer cells are incompletely understood. In four carcinoma cell lines from breast cancer, pancreatic cancer, and ovarian cancer and in ovarian cancer patient-derived cells, we analyzed stem cell phenotype and tumor growth via mRNA, miRNA, and protein expression, spheroid formation, and growth in patient-derived xenografts. We show that treatment with EMT-promoting growth factors or SNAI1 overexpression increased stemness and reduced let-7 expression, while SNAI1 knockdown reduced stemness and restored let-7 expression. Rescue experiments demonstrate that the pro-stemness effects of SNAI1 are mediated via let-7. In vivo, nanoparticle-delivered siRNA successfully knocked down SNAI1 in orthotopic patient-derived xenografts, accompanied by reduced stemness and increased let-7 expression, and reduced tumor burden. Chromatin immunoprecipitation demonstrated that SNAI1 binds the promoters of various let-7 family members, and luciferase assays revealed that SNAI1 represses let-7 transcription. In conclusion, the SNAI1/let-7 axis is an important component of stemness pathways in cancer cells, and this study provides a rationale for future work examining this axis as a potential target for cancer stem cell-specific therapies.Keywords
All Related Versions
Funding Information
- California Institute for Regenerative Medicine (DISC1-10588)
- Loma Linda University (2140226, 2170240)
This publication has 69 references indexed in Scilit:
- ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial CellsThe American Journal of Pathology, 2012
- Epithelial-Mesenchymal Transition-Derived Cells Exhibit Multilineage Differentiation Potential Similar to Mesenchymal Stem CellsStem Cells, 2010
- Mesoporous Silica Nanoparticles Facilitate Delivery of siRNA to Shutdown Signaling Pathways in Mammalian CellsSmall, 2010
- Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor ProgressionJournal of Mammary Gland Biology and Neoplasia, 2010
- Cancer stem cells: mirage or reality?Nature Medicine, 2009
- Association of reactive oxygen species levels and radioresistance in cancer stem cellsNature, 2009
- Connecting microRNA Genes to the Core Transcriptional Regulatory Circuitry of Embryonic Stem CellsCell, 2008
- Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug DeliveryACS Nano, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumorsNature Genetics, 2008